SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody. (2020)
Attributed to:
Disease mechanisms and therapy for inherited disorders of the neuromuscular synapse.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1212/nxi.0000000000000645
PubMed Identifier: 31831571
Publication URI: http://europepmc.org/abstract/MED/31831571
Type: Journal Article/Review
Volume: 7
Parent Publication: Neurology(R) neuroimmunology & neuroinflammation
Issue: 1
ISSN: 2332-7812